Alan C. Shapiro

Corporate Officer/Principal presso USC Marshall School of Business

78 anni

Consumer Services

Health Technology

Miscellaneous

Profilo

Dr. Alan C.
Shapiro is Independent Director at Ocata Therapeutics, Inc. and a Professor at USC Marshall School of Business.
He is on the Board of Directors at Ocata Therapeutics, Inc. and Pacific Corporate Group Private Equity Fund.
Dr. Shapiro was previously employed as an Assistant Professor by University of Pennsylvania.
He received his undergraduate degree from Rice University and a doctorate degree from Carnegie Mellon University.

Posizioni attive di Alan C. Shapiro

Società	Posizione	Inizio
USC Marshall School of Business	Corporate Officer/Principal	-

Tutte le posizioni attive di Alan C. Shapiro

Precedenti posizioni note di Alan C. Shapiro

Società	Posizione	Fine
OCATA THERAPEUTICS INC	Direttore/Membro del Consiglio	10/02/2016
Pacific Corporate Group Private Equity Fund Pacific Corporate Group Private Equity Fund Investment Trusts/Mutual FundsMiscellaneous Part of Mitsubishi Corp., Pacific Corporate Group Private Equity Fund is an Open-End Investment Fund/Unit Trust. The company is based in La Jolla, CA.	Direttore/Membro del Consiglio	-
University of Pennsylvania	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Alan C. Shapiro

Formazione di Alan C. Shapiro

Carnegie Mellon University	Doctorate Degree
Rice University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Alan C. Shapiro

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Astellas Institute for Regenerative Medicine Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA.	Health Technology
Pacific Corporate Group Private Equity Fund Pacific Corporate Group Private Equity Fund Investment Trusts/Mutual FundsMiscellaneous Part of Mitsubishi Corp., Pacific Corporate Group Private Equity Fund is an Open-End Investment Fund/Unit Trust. The company is based in La Jolla, CA.	Miscellaneous

Aziende private